Neuroprotection by cord blood neural progenitors involves antioxidants, neurotrophic and angiogenic factors

Experimental Neurology

Volumn 216, Issue 1, 2009, Pages 83-94

  Arien Zakay, Hadar ^a   Lecht, Shimon ^a   Bercu, Marian M ^a   Tabakman, Rinat ^a   Kohen, Ron ^a   Galski, Hanan ^b   Nagler, Arnon ^b   Lazarovici, Philip ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

Author keywords

Cord blood progenitors; FGF 2; Free radicals; Neuroprotection; NGF; Oxygen glucose deprivation; PC12 cells; VEGF

Indexed keywords

ANTIOXIDANT; CASPASE 3; FIBROBLAST GROWTH FACTOR; FREE RADICAL; K 252A; LACTATE DEHYDROGENASE; NERVE GROWTH FACTOR; NERVE GROWTH FACTOR RECEPTOR; PROTEIN TYROSINE KINASE A; VASCULOTROPIN;

ANIMAL CELL; ARTICLE; CELL INTERACTION; CONTROLLED STUDY; CYCLIC POTENTIOMETRY; GENE EXPRESSION REGULATION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; NERVE CELL CULTURE; NERVE CELL LESION; NEUROPROTECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UMBILICAL CORD BLOOD;

ANGIOGENIC PROTEINS; ANIMALS; ANTIOXIDANTS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELLS, CULTURED; COCULTURE TECHNIQUES; CYTOPROTECTION; FETAL BLOOD; FREE RADICALS; HUMANS; HYPOXIA-ISCHEMIA, BRAIN; NEOVASCULARIZATION, PHYSIOLOGIC; NERVE GROWTH FACTORS; NEURONS; OXIDATION-REDUCTION; OXIDATIVE STRESS; PC12 CELLS; PHENOTYPE; RATS; STEM CELLS; STROKE;

EID: 59949089198     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2008.11.006     Document Type: Article

References (68)

1. Abu-Raya S., Tabakman R., Blaugrund E., Trembovler V., and Lazarovici P. Neuroprotective and neurotoxic effects of monoamine oxidase-B inhibitors and derived metabolites under ischemia in PC12 cells. Eur. J. Pharmacol. 434 (2002) 109-116
2. Alexanian A.R., Maiman D.J., Kurpad S.N., and Gennarelli T.A. In vitro and in vivo characterization of neurally modified mesenchymal stem cells induced by epigenetic modifiers and neural stem cell environment. Stem Cells Dev. 17 (2008) 1123-1130
3. Alzheimer C., and Werner S. Fibroblast growth factors and neuroprotection. Adv. Exp. Med. Biol. 513 (2002) 335-351
4. Andsberg G., Kokaia Z., Klein R.L., Muzyczka N., Lindvall O., and Mandel R.J. Neuropathological and behavioral consequences of adeno-associated viral vector-mediated continuous intrastriatal neurotrophin delivery in a focal ischemia model in rats. Neurobiol. Dis. 9 (2002) 187-204
5. Arien-Zakay H., Nagler A., Galski H., and Lazarovici P. Neuronal conditioning medium and nerve growth factor induce neuronal differentiation of collagen-adherent progenitors derived from human umbilical cord blood. J. Mol. Neurosci. 32 (2007) 179-191
6. Barnabé-Heider F., and Miller F.D. Endogenously produced neurotrophins regulate survival and differentiation of cortical progenitors via distinct signaling pathways. J. Neurosci. 23 (2003) 5149-5160
7. Boniece I.R., and Wagner J.A. Growth factors protect PC12 cells against ischemia by a mechanism that is independent of PKA, PKC, and protein synthesis. J. Neurosci. 13 (1993) 4220-4228
8. Buzańska L., Jurga M., and Domańska-Janik K. Neuronal differentiation of human umbilical cord blood neural stem-like cell line. Neurodegener. Dis. 3 (2006) 19-26
9. Chen J., Sanberg P.R., Li Y., Wang L., Lu M., Willing A.E., Sanchez-Ramos J., and Chopp M. Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke 32 (2001) 2682-2688
10. Chen N., Hudson J.E., Walczak P., Misiuta I., Garbuzova-Davis S., Jiang L., Sanchez-Ramos J., Sanberg P.R., Zigova T., and Willing A.E. Human umbilical cord blood progenitors: the potential of these hematopoietic cells to become neural. Stem Cells 23 (2005) 1560-1570
11. Cho S.W., Gwak S.J., Kang S.W., Bhang S.H., Won Song K.W., Yang Y.S., Choi C.Y., and Kim B.S. Enhancement of angiogenic efficacy of human cord blood cell transplantation. Tissue Eng. 12 (2006) 1651-1661
12. Chopp M., and Li Y. Transplantation of bone marrow stromal cells for treatment of central nervous system diseases. Adv. Exp. Med. Biol. 585 (2006) 49-64
13. Claffey K.P., Wilkison W.O., and Spiegelman B.M. Vascular endothelial growth factor. Regulation by cell differentiation and activated second messenger pathways. J. Biol. Chem. 267 (1992) 16317-16322
14. De Angeli S., Di Liddo R., Buoro S., Toniolo L., Conconi M.T., Belloni A.S., Parnigotto P.P., and Nussdorfer G.G. New immortalized human stromal cell lines enhancing in vitro expansion of cord blood hematopoietic stem cells. Int. J. Mol. Med. 13 (2004) 363-371
15. Deleyrolle L., Marchal-Victorion S., Dromard C., Fritz V., Saunier M., Sabourin J.C., Tran Van Ba C., Privat A., and Hugnot J.P. Exogenous and fibroblast growth factor 2/epidermal growth factor-regulated endogenous cytokines regulate neural precursor cell growth and differentiation. Stem Cells 24 (2006) 748-762
16. Fujita K., Lazarovici P., and Guroff G. Regulation of the differentiation of PC12 pheochromocytoma cells. Environ. Health Perspect. 80 (1989) 127-142
17. Genestra M. Oxyl radicals, redox-sensitive signalling cascades and antioxidants. Cell Signal. 19 (2007) 1807-1819
18. Gill J.S., Schenone A.E., Podratz J.L., and Windebank A.J. Autocrine regulation of neurite outgrowth from PC12 cells by nerve growth factor. Brain Res. Mol. Brain Res. 57 (1998) 123-131
19. Glantz L., Avramovich A., Trembovler V., Gurvitz V., Kohen R., Eidelman L.A., and Shohami E. Ischemic preconditioning increases antioxidants in the brain and peripheral organs after cerebral ischemia. Exp. Neurol. 192 (2005) 117-124
20. Greenberg D.A., and Jin K. From angiogenesis to neuropathology. Nature 438 (2005) 954-959
21. Grothe C., and Meisinger C. The multifunctionality of FGF-2 in the adrenal medulla. Anat. Embryol. (Berl.) 195 (1997) 103-111
22. Harris D.T., Badowski M., Ahmad N., and Gaballa M.A. The potential of cord blood stem cells for use in regenerative medicine. Expert Opin. Biol. Ther. 7 (2007) 1311-1322
23. Hau S., Reich D.M., Scholz M., Naumann W., Emmrich F., Kamprad M., and Boltze J. Evidence for neuroprotective properties of human umbilical cord blood cells after neuronal hypoxia in vitro. BMC Neurosci. 9 (2008) 1-15
24. Ikeda N., Nonoguchi N., Zhao M.Z., Watanabe T., Kajimoto Y., Furutama D., Kimura F., Dezawa M., Coffin R.S., Otsuki Y., Kuroiwa T., and Miyatake S. Bone marrow stromal cells that enhanced fibroblast growth factor-2 secretion by herpes simplex virus vector improve neurological outcome after transient focal cerebral ischemia in rats. Stroke 36 (2005) 2725-2730
25. Italiano Jr. J.E., Richardson J.L., Patel-Hett S., Battinelli E., Zaslavsky A., Short S., Ryeom S., Folkman J., and Klement G.L. Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released. Blood 111 (2008) 1227-1233
26. Katzir I., Shani J., Regev K., Shabashov D., and Lazarovici P. A quantitative bioassay for nerve growth factor, using PC12 clones expressing different levels of trkA receptors. J. Mol. Neurosci. 18 (2002) 251-264
27. Khaliq A., Patel B., Jarvis-Evans J., Moriarty P., McLeod D., and Boulton M. Oxygen modulates production of bFGF and TGF-beta by retinal cells in vitro. Exp. Eye Res. 60 (1995) 415-423
28. Kirkland R.A., Saavedra G.M., and Franklin J.L. Rapid activation of antioxidant defenses by nerve growth factor suppresses reactive oxygen species during neuronal apoptosis: evidence for a role in cytochrome c redistribution. J. Neurosci. 27 (2007) 11315-11326
29. Kohen R., Vellaichamy E., Hrbac J., Gati I., and Tirosh O. Quantification of the overall reactive oxygen species scavenging capacity of biological fluids and tissues. Free Radic. Biol. Med. 28 (2000) 871-879
30. Koizumi S., Contreras M.L., Matsuda Y., Hama T., Lazarovici P., and Guroff G. K-252a: a specific inhibitor of the action of nerve growth factor on PC 12 cells. J. Neurosci. 8 (1988) 715-721
31. Lazarovici P., Matsuda Y., Kaplan D., and Guroff G. The protein kinase inhibitors K-252a and staurosporine as modifiers of neurotrophin receptor signal transduction. In: Gutman Y., and Lazarovici P. (Eds). Toxin and Signal Transduction. Cell. Mol. Mech. Toxin Action (1997), Harwood Academic Pub., Amsterdam 69-94
32. Lee H.J., Kim K.S., Park I.H., and Kim S.U. Human neural stem cells over-expressing VEGF provide neuroprotection, angiogenesis and functional recovery in mouse stroke model. PLoS ONE 2 (2007) e156
33. Levy A.P., Levy N.S., Wegner S., and Goldberg M.A. Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J. Biol. Chem. 270 (1995) 13333-13340
34. Lindvall O., Ernfors P., Bengzon J., Kokaia Z., Smith M.L., Siesjö B.K., and Persson H. Differential regulation of mRNAs for nerve growth factor, brain-derived neurotrophic factor, and neurotrophin 3 in the adult rat brain following cerebral ischemia and hypoglycemic coma. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 648-652
35. Liu C.H., and Hwang S.M. Cytokine interactions in mesenchymal stem cells from cord blood. Cytokine 32 (2005) 270-279
36. Liu P.K., Robertson C.S., and Valadka A. The association between neuronal nitric oxide synthase and neuronal sensitivity in the brain after brain injury. Ann. N.Y. Acad. Sci. 962 (2002) 226-241
37. Liu Y., Song X.D., Liu W., Zhang T.Y., and Zuo J. Glucose deprivation induces mitochondrial dysfunction and oxidative stress in PC12 cell line. J. Cell. Mol. Med. 7 (2003) 49-56
38. Low C.B., Liou Y.C., and Tang B.L. Neural differentiation and potential use of stem cells from the human umbilical cord for central nervous system transplantation therapy. J. Neurosci. Res. 86 (2008) 1670-1679
39. Lu D., Sanberg P.R., Mahmood A., Li Y., Wang L., Sanchez-Ramos J., and Chopp M. Intravenous administration of human umbilical cord blood reduces neurological deficit in the rat after traumatic brain injury. Cell Transplant 11 (2002) 275-281
40. Majka M., Janowska-Wieczorek A., Ratajczak J., Ehrenman K., Pietrzkowski Z., Kowalska M.A., Gewirtz A.M., Emerson S.G., and Ratajczak M.Z. Numerous growth factors, cytokines, and chemokines are secreted by human CD34(+) cells, myeloblasts, erythroblasts, and megakaryoblasts and regulate normal hematopoiesis in an autocrine/paracrine manner. Blood 97 (2001) 3075-3085
41. Martino G., and Pluchino S. The therapeutic potential of neural stem cells. Nat. Rev. Neurosci. 7 (2006) 395-406
42. Meier C., Middelanis J., Wasielewski B., Neuhoff S., Roth-Haerer A., Gantert M., Dinse H.R., Dermietzel R., and Jensen A. Spastic paresis after perinatal brain damage in rats is reduced by human cord blood mononuclear cells. Pediatr. Res. 59 (2006) 244-249
43. Meisinger C., Zeschnigk C., and Grothe C. In vivo and in vitro effect of glucocorticoids on fibroblast growth factor (FGF)-2 and FGF receptor 1 expression. J. Biol. Chem. 271 (1996) 16520-16525
44. Middeke M., Hoffmann S., Hassan I., Wunderlich A., Hofbauer L.C., and Zielke A. In vitro and in vivo angiogenesis in PC12 pheochromocytoma cells is mediated by vascular endothelial growth factor. Exp. Clin. Endocrinol. Diabetes 110 (2002) 386-392
45. Mills E.M., Takeda K., Yu Z.X., Ferrans V., Katagiri Y., Jiang H., Lavigne M.C., Leto T.L., and Guroff G. Nerve growth factor treatment prevents the increase in superoxide produced by epidermal growth factor in PC12 cells. J. Biol. Chem. 273 (1998) 22165-22168
46. Mori A., Liu J., Wang X., and Kawai M. Free radical scavenging by brain homogenate: implication to free radical damage and antioxidant defense in brain. Neurochem. Int. 24 (1994) 201-207
47. Mylotte L.A., Duffy A.M., Murphy M., O'Brien T., Samali A., Barry F., and Szegezdi E. Metabolic flexibility permits mesenchymal stem cell survival in an ischemic environment. Stem Cells 26 (2008) 1325-1336
48. Neuhoff S., Moers J., Rieks M., Grunwald T., Jensen A., Dermietzel R., and Meier C. Proliferation, differentiation, and cytokine secretion of human umbilical cord blood-derived mononuclear cells in vitro. Exp. Hematol. 35 (2007) 1119-1131
49. Newman M.B., Emerich D.F., Borlongan C.V., Sanberg C.D., and Sanberg P.R. Use of human umbilical cord blood (HUCB) cells to repair the damaged brain. Curr. Neurovasc. Res. 1 (2004) 269-281
50. Raedt R., and Boon P. Cell therapy for neurological disorders: a comprehensive review. Acta Neurol. Belg. S105 (2005) 158-170
51. Roux P.P., Dorval G., Boudreau M., Angers-Loustau A., Morris S.J., Makkerh J., and Barker P.A. K252a and CEP1347 are neuroprotective compounds that inhibit mixed-lineage kinase-3 and induce activation of Akt and ERK. J Biol Chem. 277 (2002) 49473-49480
52. Sanchez-Ramos J.R. Neural cells derived from adult bone marrow and umbilical cord blood. J. Neurosci. Res. 69 (2002) 880-893
53. Sarker K.P., Yamahata H., Nakata M., Arisato T., Nakajima T., Kitajima I., and Maruyama I. Recombinant thrombomodulin inhibits thrombin-induced vascular endothelial growth factor production in neuronal cells. Haemostasis 29 (1999) 343-352
54. Seta K.A., Spicer Z., Yuan Y., Lu G., and Millhorn D.E. Responding to hypoxia: lessons from a model cell line. Sci. STKE 2002 (2002) RE11
55. Sofroniew M.V., Howe C.L., and Mobley W.C. Nerve growth factor signaling, neuroprotection, and neural repair. Annu. Rev. Neurosci. 24 (2001) 1217-1281
56. Song B.W., Vinters H.V., Wu D., and Pardridge W.M. Enhanced neuroprotective effects of basic fibroblast growth factor in regional brain ischemia after conjugation to a blood-brain barrier delivery vector. J. Pharmacol. Exp. Ther. 301 (2002) 605-610
57. Storkebaum E., Lambrechts D., and Carmeliet P. VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection. Bioessays 26 (2004) 943-954
58. Sun F.Y., and Guo X. Molecular and cellular mechanisms of neuroprotection by vascular endothelial growth factor. J. Neurosci. Res. 79 (2005) 180-184
59. Sun W., Buzanska L., Domanska-Janik K., Salvi R.J., and Stachowiak M.K. Voltage-sensitive and ligand-gated channels in differentiating neural stem-like cells derived from the nonhematopoietic fraction of human umbilical cord blood. Stem Cells 23 (2005) 931-945
60. Tabakman R., Lazarovici P., and Kohen R. Neuroprotective effects of carnosine and homocarnosine on pheochromocytoma PC12 cells exposed to ischemia. J. Neurosci. Res. 68 (2002) 463-469
61. Tabakman R., Jiang H., Levine R.A., Kohen R., and Lazarovici P. Apoptotic characteristics of cell death and the neuroprotective effect of homocarnosine on pheochromocytoma PC12 cells exposed to ischemia. J. Neurosci. Res. 75 (2004) 499-507
62. Tabakman R., Jiang H., Schaefer E., Levine R.A., and Lazarovici P. Nerve growth factor pretreatment attenuates oxygen and glucose deprivation-induced c-Jun amino-terminal kinase 1 and stress-activated kinases p38alpha and p38beta activation and confers neuroprotection in the pheochromocytoma PC12 model. J. Mol. Neurosci. 22 (2004) 237-250
63. Tabakman R., Lecht S., Sephanova S., Arien-Zakay H., and Lazarovici P. Interactions between the cells of the immune and nervous system: neurotrophins as neuroprotection mediators in CNS injury. Prog. Brain. Res. 146 (2004) 387-401
64. Tabakman R., Jiang H., Shahar I., Arien-Zakay H., Levine R.A., and Lazarovici P. Neuroprotection by NGF in the PC12 in vitro OGD model: involvement of mitogen-activated protein kinases and gene expression. Ann. N.Y. Acad. Sci. 1053 (2005) 84-96
65. Theus M.H., Wei L., Cui L., Francis K., Hu X., Keogh C., and Yu S.P. In vitro hypoxic preconditioning of embryonic stem cells as a strategy of promoting cell survival and functional benefits after transplantation into the ischemic rat brain. Exp. Neurol. 210 (2008) 656-670
66. Vaudry D., Stork P.J., Lazarovici P., and Eiden L.E. Signaling pathways for PC12 cell differentiation: making the right connections. Science 296 (2002) 1648-1649
67. Vendrame M., Gemma C., de Mesquita D., Collier L., Bickford P.C., Sanberg C.D., Sanberg P.R., Pennypacker K.R., and Willing A.E. Anti-inflammatory effects of human cord blood cells in a rat model of stroke. Stem Cells Dev. 14 (2005) 595-604
68. Zaheer A., Zhong W., and Lim R. Expression of mRNAs of multiple growth factors and receptors by neuronal cell lines: detection with RT-PCR. Neurochem. Res. 20 (1995) 1457-1463